Quantcast

Latest Rofecoxib Stories

2006-08-23 08:00:00

CHICAGO (Reuters) - Drugmaker Merck & Co. on Wednesday gave preliminary results of a study of its investigational painkiller Arcoxia, the planned successor to Vioxx, which was pulled off the market in 2004 after being linked to stroke and heart attack. Merck said the study, comparing Arcoxia with the anti-inflammatory drug diclofenac, found the "relative risk" of certain cardiovascular events was similar. The incidence of patients withdrawing from the study due to side effects related to...

2006-08-17 16:51:22

By Peter Henderson NEW ORLEANS (Reuters) - Merck & Co. on Thursday suffered a double setback when a federal jury awarded $51 million to a former user of its withdrawn pain medicine Vioxx, and a New Jersey judge threw out a Vioxx verdict that had favored the drug maker and ordered a new trial. The news sent its shares down 5.7 percent, and evened the score between Merck and plaintiffs in Vioxx cases at four victories apiece. The company is facing at least 14,200 other lawsuits...

2006-08-17 14:42:31

By Peter Henderson NEW ORLEANS (Reuters) - Merck & Co. on Thursday suffered a double setback when a federal jury awarded $51 million to a former user of its withdrawn pain medicine Vioxx, and a New Jersey judge threw out a Vioxx verdict that had favored the drug maker and ordered a new trial. The news sent the company's shares down more than 5 percent, and evened the score between Merck and plaintiffs at four victories a piece. The company is facing at least 14,200 other...

2006-08-17 13:50:09

By Peter Henderson NEW ORLEANS (Reuters) - Merck & Co. on Thursday suffered a double setback when a federal jury awarded $51 million to a former user of its withdrawn pain medicine Vioxx, and a New Jersey judge threw out a Vioxx verdict that had favored the drug maker and ordered a new trial. The news sent the company's shares down more than 5 percent, and evened the score between Merck and plaintiffs at four victories a piece. The company is facing at least 14,200 other...

2006-08-17 13:32:31

By Peter Henderson NEW ORLEANS (Reuters) - A federal jury on Thursday found that Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, and awarded $51 million to the plaintiff. The New Orleans jury, in the second federal trial involving a Vioxx product-liability lawsuit, found that Merck had knowingly misrepresented or failed to disclose a material fact to the plaintiff's physicians and that doctors in the case and the...

2006-08-17 10:07:03

Corrects first paragraph to say Merck was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, instead of negligent in warning plaintiff. NEW YORK (Reuters) - A federal jury on Thursday found Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine, Vioxx. The jury, which said that doctors in the case and the plaintiff himself were not at fault, said that Merck had knowingly misrepresented or failed...

2006-08-17 12:19:04

By Peter Henderson NEW ORLEANS (Reuters) - A federal jury on Thursday found that Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine Vioxx, and awarded $51 million to the plaintiff. The New Orleans jury, in the second federal trial involving a Vioxx product-liability lawsuit, found that Merck had knowingly misrepresented or failed to disclose a material fact to the plaintiff's physicians and that doctors in the case and the...

2006-08-17 10:04:55

NEW YORK (Reuters) - A federal jury on Thursday found Merck & Co. Inc. was negligent and knowingly made misrepresentations about its withdrawn pain medicine, Vioxx. The jury, which said that doctors in the case and the plaintiff himself were not at fault, said that Merck had knowingly misrepresented or failed to disclose a material fact to the plaintiff's physicians. The jury said adequate compensation would be $50 million, but has not yet decided on punitive damages in the case.

2006-08-03 08:00:00

LOS ANGELES -- A Los Angeles jury gave Merck & Co. Inc. another court victory on Wednesday when it found the company not responsible for the heart attack of a 71-year-old retired construction manager who had taken the withdrawn pain medicine Vioxx. "The jury found Merck not liable," said Casey Stavropoulos, a spokeswoman for the company. Merck has now won five of the eight Vioxx suits that have been decided in court. The Los Angeles Superior Court case, the first Vioxx lawsuit to go to...

2006-08-01 20:55:00

NEW YORK -- All painkillers of the type known as nonsteroidal anti-inflammatory drugs (NSAIDs) seem to increase the risk of having a heart attack, according to a population-based study conducted in Finland. The finding applies not only to selective COX-2 inhibitors such as celecoxib but also to non-selective drugs like ibuprofen or naproxen. "Our results do not support the view that COX-selectivity alone determines the cardiovascular adverse effects of NSAIDs," lead investigator Dr. Arja...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related